Watson v. Philip Morris Companies Inc.

Supreme Court of the United States · Federal Courts

Federal CourtsFederal officer removal28 U.S.C. § 1442(a)(1)federal officer removalacting underprivate entitiesregulatory complianceFTC

Facts

Petitioners filed an Arkansas state-court action alleging that Philip Morris deceptively marketed certain cigarettes as "light" while manipulating cigarette design so the products would register lower tar and nicotine levels under the Cambridge Filter Method than consumers would actually receive when smoking them. Philip Morris removed the case to federal court under 28 U.S.C. § 1442(a)(1), arguing that the challenged conduct occurred while it was acting under the Federal Trade Commission. Philip Morris relied on the FTC's detailed specifications, supervision, and monitoring of cigarette testing and advertising practices. It also argued that the FTC had effectively delegated cigarette-testing responsibility to an industry-financed laboratory that Philip Morris used.

Issue

Does a private company act "under" a federal officer within the meaning of 28 U.S.C. § 1442(a)(1) when a federal agency directs, supervises, and monitors the company's activities in considerable detail? More specifically, does Philip Morris's relationship with the FTC regarding cigarette testing and advertising permit federal officer removal?

Rule

For purposes of 28 U.S.C. § 1442(a)(1), a private person acts "under" a federal officer only when the relationship involves subjection, guidance, or control and the private person is assisting, or helping carry out, the duties or tasks of the federal superior. Mere compliance or noncompliance with federal laws, rules, regulations, or even highly detailed and closely monitored regulatory orders does not by itself qualify as "acting under" a federal officer.

🔒

See the holding & full analysis

Create a free KwikCourt account to unlock the rest of this brief — and practice the case.

The court's holding and reasoning
Doctrine tests, pitfalls & exam hypotheticals
10 practice questions + 4 AI-graded essays on this case

Free sample · practice this case

Test yourself

One of 10 multiple-choice questions for this case. Pick an answer to see why.

Blue Mesa Pharma, a drug manufacturer in Denver, follows an intricate set of federal labeling and marketing regulations administered by the National Therapeutics Bureau, including mandatory testing protocols, periodic audits, and detailed reporting requirements. Patients sue Blue Mesa in Colorado state court for deceptive advertising under state consumer-protection law, and Blue Mesa removes under 28 U.S.C. § 1442(a)(1).

Is removal most likely proper?

Explanation. Removal is improper. The majority held that a private firm is not acting under a federal officer merely because it complies with highly detailed federal rules and is closely supervised and monitored. The required relationship must involve assistance in carrying out the federal superior’s duties or tasks, not ordinary compliance with regulation. (Derived from Watson v. Philip Morris Companies Inc. (n.d.).)